Skip to main content
Caplight Logo









OncoTAb

OncoTAb

Private
Charlotte, North CarolinaHealthcare & Life Scienceshttps://oncotab.com/

Last Round

Grant

Oct 5, 2016

Total Funding Raised

$2.79M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

OncoTAb is a diagnostic equipment company that develops a blood test kit designed for early-stage breast cancer detection.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical Imaging, Drug Discovery

Business Model

B2B2C

Customer Profile

Government Contracts, Hardware Sales, Revenue Share

AI Layer

Non-AI

Keywords

cancer diagnosticsliquid biopsyearly cancer detectionbreast cancer diagnosticsnon-invasive diagnosticstheranosticslaboratory developed testLDTtumor marker testdense breast tissuecancer therapeuticstMUC1 targettumor imagingbispecific antibodyCLIA laboratory

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OncoTAb Comparables

Compare OncoTAb with similar companies based on industry and business-model similarity.

OncoTAb comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Mammogen
89%
Syantra Inc.
81%
Astrin Biosciences
79%

OncoTAb Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 5, 2016

Key People

Founding team and executive leadership

Pinku Mukherjee

Founder, President & Chief Science Officer

Founding Team

Rahul Puri

Chief Executive Officer, Director

Executive Team

OncoTAb Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors grew 60% MoM.

  • Jun 18, 2026

    Monthly visitors grew 179% MoM, from 184 to 514.

OncoTAb Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OncoTAb Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OncoTAb's valuation, stock price, and market status.

Firmographic Details

HeadquartersCharlotte, North Carolina
Employee Range3
Year Founded2010
Last FundingOct 5, 2016

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?